American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 661-671.e1, April 2010

Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

  • L. Jay Katz

      Affiliations

    • Wills Eye Hospital, Philadelphia, Pennsylvania
    • Corresponding Author InformationInquiries to L. Jay Katz, Glaucoma Service, Wills Eye Hospital, 840 Walnut Street, Suite 1110, Philadelphia, PA 19107
    • ,
  • John S. Cohen

      Affiliations

    • Cincinnati Eye Institute, Cincinnati, Ohio
    • ,
  • Amy L. Batoosingh

      Affiliations

    • Allergan, Inc, Irvine, California
    • ,
  • Carlos Felix

      Affiliations

    • Allergan, Inc, Irvine, California
    • ,
  • Vincent Shu

      Affiliations

    • Allergan, Inc, Irvine, California
    • ,
  • Rhett M. Schiffman

      Affiliations

    • Allergan, Inc, Irvine, California

Accepted 1 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9394(09)00906-4

doi:10.1016/j.ajo.2009.12.003

American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 661-671.e1, April 2010

Article Tools

* Image Usage & Resolution